Citation Impact
Citing Papers
A Novel Germline Variant in CSF3R Reduces N-Glycosylation and Exerts Potent Oncogenic Effects in Leukemia
2018 StandoutNobel
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
2016 Standout
EPSTEIN-BARR VIRUS-INDUCED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS
1999
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
2009 Standout
Secondary leukemias induced by topoisomerase-targeted drugs
1998
Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001
2002
Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children
1988
Pulmonary fungal infections after bone marrow transplantation
1988
OncogenicCSF3RMutations in Chronic Neutrophilic Leukemia and Atypical CML
2013
A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin
1999 Standout
Crohn's disease
2012 Standout
Co‐stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily
2005 StandoutNobel
Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML
2003
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome.
1989
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Acute biphenotypic leukaemia: immunophenotypic and cytogenetic analysis
1993
Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML
2008
Myelodysplasia with fibrosis: a distinct entity?
2001
A phase II study of intensive chemotherapy with fludarabine, cytarabine, and mitoxantrone in P glycoprotein-negative high-risk myelodysplastic syndromes
2004
LONG-TERM SURVIVORS OF CHILDHOOD CANCER
1997
T-Cell and NK-Cell Posttransplantation Lymphoproliferative Disorders
2007
INTERFERON-?? TREATMENT OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER IN RECIPIENTS OF SOLID ORGAN TRANSPLANTS1
1998
STATs in oncogenesis
2000 Standout
The myelodysplastic syndrome.
1989
Graft-versus-host disease
2009 Standout
An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long-term outcome in 155 patients
2000 Standout
Therapy-Related Myelodysplastic Syndrome
2007
Myelodysplastic syndrome with increased marrow fibrosis: a distinct clinico‐pathological entity
1991
Transplantation of Anergic Histoincompatible Bone Marrow Allografts
1999
Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia.
1988
Therapy-related acute myeloid leukemia secondary to inhibitors of topoisomerase II: From the bedside to the target genes
1992
A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel Disease
2010
Antifungal and Surgical Treatment of Invasive Aspergillosis: Review of 2,121 Published Cases
1990 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Analysis of prognostic factors for the outcome of marrow transplantation or further chemotherapy for patients with acute nonlymphocytic leukemia in first remission.
1989 StandoutNobel
DNA Topoisomerases and Their Poisoning by Anticancer and Antibacterial Drugs
2010 Standout
Infection in Solid-Organ Transplant Recipients
2007 Standout
Bone Marrow Transplantation for Treatment of Leukemia in Children
1988
Impact of Cytogenetics on Outcome of De Novo and Therapy-Related AML and MDS after Allogeneic Transplantation
2007
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Presentation of Epstein-Barr virus latency antigens to CD8+, interferon-γ-secreting, T lymphocytes
1999 StandoutNobel
Preservation of Fertility in Patients with Cancer
2009 Standout
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
2008 Standout
Epstein–Barr Virus Infection
2000 Standout
Bone Marrow Transplantation in the Treatment of Children with Cancer: Current Status
1987
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2003 Standout
γδ T‐cell lymphomas: a homogeneous entity?
2000
NK CELL RECEPTORS
1998 Standout
Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders
1988
Biology of Hematopoietic Stem Cells and Progenitors: Implications for Clinical Application
2003
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Evolution of the immune system in humans from infancy to old age
2015 Standout
Role of Genetic Susceptibility in Development of Treatment-Related Adverse Outcomes in Cancer Survivors
2011
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes
1997 Standout
Development of human T and natural killer cells
1995
Ordering human CD34+CD10−CD19+pre/pro-B-cell and CD19−common lymphoid progenitor stages in two pro-B-cell development pathways
2010
Prolonged STAT1 Activation Related to the Growth Arrest of Malignant Lymphoma Cells by Interferon-α
1998
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Morphology and classification of the myelodysplastic syndromes and their pathologic variants.
1996
Myeloid leukemia after hematotoxins.
1996
Polycythemia vera: myths, mechanisms, and management
2002
Thymocyte-Thymic Epithelial Cell Interaction Leads to High-Level Replication of Human Immunodeficiency Virus Exclusively in Mature CD4+CD8−CD3+Thymocytes: a Critical Role for Tumor Necrosis Factor and Interleukin-7
1999 StandoutNobel
CD34-expressing human thymocyte precursors proliferate in response to interleukin-7 but have lost myeloid differentiation potential
1993
Clonal involvement of granulocytes and monocytes, but not of T and B lymphocytes and natural killer cells in patients with myelodysplasia: analysis by X-linked restriction fragment length polymorphisms and polymerase chain reaction of the phosphoglycerate kinase gene
1992
Bone Marrow Transplant
1990 Standout
Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine
1988
Single-Cell Mass Cytometry of Differential Immune and Drug Responses Across a Human Hematopoietic Continuum
2011 StandoutScience
Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow
1992
Malignancies After Hematopoietic Stem Cell Transplantation: Many Questions, Some Answers
1998
Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes
1994 StandoutNobel
Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes
2015 Standout
Two subpopulations of human triple-negative thymic cells are susceptible to infection by human immunodeficiency virus type 1 in vitro
1994 StandoutNobel
Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung
1987
The World Health Organization (WHO) classification of the myeloid neoplasms
2002 Standout
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Treatment of Therapy-Related Leukemia and Myelodysplastic Syndrome
1993
Myeloid Leukemia after Hematotoxins
1996
The Dendritic Cell Lineage: Ontogeny and Function of Dendritic Cells and Their Subsets in the Steady State and the Inflamed Setting
2013 Standout
Induction of Epstein-Barr Virus-Specific Cytotoxic T-Lymphocyte Responses Using Dendritic Cells Pulsed With EBNA-3A Peptides or UV-Inactivated, Recombinant EBNA-3A Vaccinia Virus
1999 StandoutNobel
Works of RD Brunning being referenced
Demonstration of clonality in neutrophils using FISH in a case of chronic neutrophilic leukemia
1998
Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors
1985
Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases
1985
Posttransplant T-cell lymphoproliferative disorders--an aggressive, late complication of solid-organ transplantation
1996
Identification of novel B-lineage cells in human fetal bone marrow that coexpress CD7 [see comments]
1991